HPV Sub Peptide Pool (>95% HPLC)
€ 138.20 *
Description
This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from human papilloma virus (HPV):
| Sequence | Corresponding Catalog Peptide | Allel | |
|---|---|---|---|
| 1 | DLLLGTLNI | HPV11 E7 81-89 Peptide | HLA-A*02:01 |
| 2 | TIHDIILECV | HPV16 E6 29-38 Peptide | HLA-A*02:01 |
| 3 | YMLDLQPETT | HPV16/18 E7 11-20 Peptide | HLA-A*02:01 |
| 4 | ALQAIELQL | HPV16 E2 69-77 Peptide | HLA-A*02:01 |
| 5 | ICWGNQLFV | HPV16 L1 349-357 Peptide | HLA-A*02:01 |
| 6 | KLCLRFLSK | HPV16 E6 64-72 Peptide | HLA-A*03:01 |
| 7 | CYSLYGTTL | HPV16/18 E6 87-95 Peptide | HLA-A*24:01 |
| 8 | EYRHYCYSL | HPV16/18 E6 75-83 Peptide | HLA-A*24:02 |
| 9 | HNIRGRWTGR | HPV16/18 E6 133-142 Peptide | HLA-A*68:01 |
| 10 | AVPDDLYIK | HPV L1 296-304 Peptide | HLA-A11 |
| 11 | GIVCPICSQK | HPV16/18 E7 88-97 Peptide | HLA-A11 |
| 12 | KPTLKEYVL | HPV16 E7 5-13 Peptide | HLA-B*07:02 |
| 13 | FAFRDLCIVY | HPV16 E6 52-61 Peptide | HLA-B*35:01 |
| 14 | HDIILECV | HPV16/18 E6 31-38 Peptide | HLA-B*40:02 |
TechData
| Delivery: | 1-3 days |
| Counterion: | TFA |
| No. Peptides: | 14 peptides |
| Amount/Aliquote: | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells |
| Solubility: | Dissolve in a minimum amount of pure DMSO (40µl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. |
| Species: | Human papilloma virus |
| Application: | Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion |
| Indication: | Infectious disease, Cancer |
| Purity: | >95% HPLC-MS |
More HPV Peptide Pools